Substance Name: Ganitumab [USAN:INN]
RN: 905703-97-1
UNII: CK1441RCZ8
Note
- A fully human monoclonal antibody to insulin-like growth factor receptor 1; in Phase I trial, Dec 2009.
Molecular Formula
- C6472-H10028-N1728-O2020-S42
Classification Code
- Treatment of Cancer
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Ganitumab [USAN:INN]
Synonyms
- AMG 479
- Ganitumab
- Immunoglobulin G1, anti-(human insulin-like growth factor 1 receptor (IGF-I receptor, EC 2.7.10.1, CD221)); human monoclonal gamma1 heavy chain (222-219')-disulfide with human monoclonal kappa light chain, dimer (228-228'':231-231'')-bisdisulfide
- UNII-CK1441RCZ8
Systematic Name
- Immunoglobulin G, anti-(human insulin-like growth factor I receptor) (human monoclonal heavy chain), disulfide with human monoclonal light chain, dimer
Registry Numbers
CAS Registry Number
- 905703-97-1
FDA UNII
- CK1441RCZ8
System Generated Number
- 0905703971